Details for 2017733108
Up to date per 02.04.2026
Actions
Details for 2017733108
Granted/Registered
European Patent
20.02.2019 A
28.06.2023 B1
15.04.2016
US
201662322948 P
21.10.2016
US
201662411172 P
C07D 487/04 20060101AFI20171020BHEP
Owner
Blueprint Medicines Corporation45 Sidney Street Cambridge, MA 02139US
Representative
No representatives present
Inventor
BROOIJMANS, Natasja43 Concord Square Apt. 2 Boston, MA 02118US
BRUBAKER, Jason, D.26 Sciarappa St Unit 1 Cambridge, MA 02141US
FLEMING, Paul, E.7 Sunnyside Ave Wellesley, MA 02482US
HODOUS, Brian, L.22 Lawrence Lane Arlington, MA 02474US
KIM, Joseph, L.20 Green Way Wayland, MA 01778US
WAETZIG, Josh30 Livermore Road Waltham, MA 02451US
WILLIAMS, Brett24 Castleton St. Boston, MA 02130US
WILSON, DouglasBlueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139US
WILSON, Kevin, J.27 Beryl Street Boston, MA 02131US
CRONIN, Mark"-" deceasedUS
Information about Fees